Low-Dose Triple Antihypertensive Combination Therapy in Patients with Hypertension: A Randomized, Double-Blind, Phase II Study

References

• WeberMA, JuliusS, KjeldsenSE, et al. Blood pressure dependent and independent effects of antihypertensive treatment on clinical events in the VALUE Trial. Lancet. 2004;363:2049–2051. doi:10.1016/S0140-6736(04)16456-815207957
   PubMed Web of Science ®Google Scholar
• GradmanAH, PariseH, LefebvreP, FalveyH, LafeuilleMH, DuhMS. Initial combination therapy reduces the risk of cardiovascular events in hypertensive patients: a matched cohort study. Hypertension. 2013;61:309–318. doi:10.1161/HYPERTENSIONAHA.112.20156623184383
   PubMed Web of Science ®Google Scholar
• MillsKT, BundyJD, KellyTN, et al. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation. 2016;134:441–450. doi:10.1161/CIRCULATIONAHA.115.01891227502908
   PubMed Web of Science ®Google Scholar
• NCD Risk Factor Collaboration (NCD-RisC). Long-term and recent trends in hypertension awareness, treatment, and control in 12 high-income countries: an analysis of 123 nationally representative surveys. Lancet. 2019;394:639–651. doi:10.1016/S0140-6736(19)31145-631327564
   PubMed Web of Science ®Google Scholar
• MatersonBJ. Variability in response to antihypertensive drugs. Am J Med. 2007;120:S10–20. doi:10.1016/j.amjmed.2007.02.003
   PubMed Web of Science ®Google Scholar
• WaldDS, LawM, MorrisJK, BestwickJP, WaldNJ. Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11,000 participants from 42 trials. Am J Med. 2009;122:290–300. doi:10.1016/j.amjmed.2008.09.03819272490
   PubMed Web of Science ®Google Scholar
• ManciaG, AsmarR, AmodeoC, et al. Comparison of single-pill strategies first line in hypertension: perindopril/amlodipine versus valsartan/amlodipine. J Hypertens. 2015;33:401–411. doi:10.1097/HJH.000000000000040925380149
   PubMed Web of Science ®Google Scholar
• WilliamsB, ManciaG, SpieringW, et al. 2018 ESC/ESH guidelines for the management of arterial hypertension. Eur Heart J. 2018;39:3021–3104.30165516
   PubMed Web of Science ®Google Scholar
• WheltonPK, CareyRM, AronowWS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: executive summary: a report of the American College of Cardiology/American heart association task force on clinical practice guidelines. Hypertension. 2018;71:1269–1324. doi:10.1161/HYP.000000000000006629133354
   PubMed Web of Science ®Google Scholar
• LawMR, WaldNJ, MorrisJK, JordanRE. Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials. BMJ. 2003;326:1427. doi:10.1136/bmj.326.7404.142712829555
   PubMed Web of Science ®Google Scholar
• BennettA, ChowCK, ChouM, et al. Efficacy and safety of quarter-dose blood pressure-lowering agents: a systematic review and meta-analysis of randomized controlled trials. Hypertension. 2017;70:85–93. doi:10.1161/HYPERTENSIONAHA.117.0920228584013
   PubMed Web of Science ®Google Scholar
• HongSJ, JeongHS, HanSH, et al. Comparison of fixed-dose combinations of amlodipine/losartan potassium/chlorthalidone and amlodipine/losartan potassium in patients with stage 2 hypertension inadequately controlled with amlodipine/losartan potassium: a randomized, double-blind, multicenter, phase III study. Clin Ther. 2017;39:2049–2060. doi:10.1016/j.clinthera.2017.08.01328939406
   PubMed Web of Science ®Google Scholar
• Hanmi Pharmaceutical Company Ltd. and Seoul National University Bundang Hospital. Pharmacokinetic interaction between HGP0904, HGP0608 and HGP1405. 10, 2014 Available from: https://ClinicalTrials.gov/show/NCT02387554. Accessed 1224, 2020.
   Google Scholar
• ParkCG, YounHJ, ChaeSC, et al. Evaluation of the dose-response relationship of amlodipine and losartan combination in patients with essential hypertension: an 8-week, randomized, double-blind, factorial, phase II, multicenter study. Am J Cardiovasc Drugs. 2012;12:35–47. doi:10.2165/11597170-000000000-0000022217192
   PubMed Web of Science ®Google Scholar
• LittlejohnTW, JonesSW, ZhangJ, HsuH, KeefeDL. Efficacy and safety of aliskiren and amlodipine combination therapy in patients with hypertension: a randomized, double-blind, multifactorial study. J Hum Hypertens. 2013;27:321–327. doi:10.1038/jhh.2012.4223076450
   PubMed Web of Science ®Google Scholar
• Boehringer Ingelheim. Telmisartan (Micardis) and Amlodipine (Norvasc) - Factorial Design Study for the Treatment of Hypertension. 3, 2007 Availble from: https://ClinicalTrials.gov/show/NCT00281580. Accessed 1224, 2020.
   Google Scholar
• WaldDS, MorrisJK, WaldNJ. Randomized Polypill crossover trial in people aged 50 and over. PLoS One. 2012;7:e41297. doi:10.1371/journal.pone.004129722815989
   PubMed Web of Science ®Google Scholar
• MahmudA, FeelyJ. Low-dose quadruple antihypertensive combination: more efficacious than individual agents–a preliminary report. Hypertension. 2007;49:272–275. doi:10.1161/01.HYP.0000254479.66645.a317178976
   PubMed Web of Science ®Google Scholar
• ChowCK, ThakkarJ, BennettA, et al. Quarter-dose quadruple combination therapy for initial treatment of hypertension: placebo-controlled, crossover, randomised trial and systematic review. Lancet. 2017;389:1035–1042. doi:10.1016/S0140-6736(17)30260-X28190578
   PubMed Web of Science ®Google Scholar
• LaurentS, ManciaG, PoulterN. Perindopril 3.5 mg/amlodipine 2.5 mg versus renin-angiotensin system inhibitor monotherapy as first-line treatment in hypertension: a combined analysis. J Hypertens. 2018;36:1915–1920. doi:10.1097/HJH.000000000000176629927844
   PubMed Web of Science ®Google Scholar
• WebsterR, SalamA, de SilvaHA, et al. Fixed low-dose triple combination antihypertensive medication vs usual care for blood pressure control in patients with mild to moderate hypertension in Sri Lanka: a randomized clinical trial. JAMA. 2018;320:566–579. doi:10.1001/jama.2018.1035930120478
   PubMed Web of Science ®Google Scholar
• LungT, JanS, de SilvaHA, et al. Fixed-combination, low-dose, triple-pill antihypertensive medication versus usual care in patients with mild-to-moderate hypertension in Sri Lanka: a within-trial and modelled economic evaluation of the TRIUMPH trial. Lancet Glob Health. 2019;7:e1359–e1366. doi:10.1016/S2214-109X(19)30343-231477545
   PubMed Web of Science ®Google Scholar